These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28502490)

  • 1. Cardiovascular disease prevalence and insulin resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study.
    Ikezaki H; Ai M; Schaefer EJ; Otokozawa S; Asztalos BF; Nakajima K; Zhou Y; Liu CT; Jacques PF; Cupples LA; Furusyo N
    J Clin Lipidol; 2017; 11(2):348-356. PubMed ID: 28502490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study.
    Ikezaki H; Ai M; Schaefer EJ; Otokozawa S; Asztalos BF; Nakajima K; Zhou Y; Liu CT; Jacques PF; Cupples LA; Furusyo N
    Sci Rep; 2016 Nov; 6():36725. PubMed ID: 27830830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid atherosclerosis and cardiovascular risk factors: a comparison of residents of a rural area of Okinawa with residents of a typical suburban area of Fukuoka, Japan.
    Tatsukawa M; Sawayama Y; Maeda N; Okada K; Furusyo N; Kashiwagi S; Hayashi J
    Atherosclerosis; 2004 Feb; 172(2):337-43. PubMed ID: 15019544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
    Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
    Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years.
    Rahman Al-Nuaim A
    Int J Cardiol; 1997 Dec; 62(3):227-35. PubMed ID: 9476683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: the Suita study.
    Arai H; Kokubo Y; Watanabe M; Sawamura T; Ito Y; Minagawa A; Okamura T; Miyamato Y
    J Atheroscler Thromb; 2013; 20(2):195-203. PubMed ID: 23076217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Reed ML; Kurth T; Fanning KM; Buse DC
    Headache; 2017 Nov; 57(10):1507-1521. PubMed ID: 28990165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in insulin resistance and cardiovascular disease risk.
    Kim SH; Reaven G
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1716-21. PubMed ID: 24064694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between insulin resistance and risk factors for cardiovascular disease in Japanese non-insulin-dependent diabetic patients.
    Wasada T; Kuroki H; Arii H; Maruyama A; Aoki K; Katsumori K; Saito S; Hanada H; Omori Y
    Diabetes Res Clin Pract; 1994 Oct; 25(3):191-8. PubMed ID: 7851274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study.
    Frankel DS; Meigs JB; Massaro JM; Wilson PW; O'Donnell CJ; D'Agostino RB; Tofler GH
    Circulation; 2008 Dec; 118(24):2533-9. PubMed ID: 19029465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better association of waist circumference with insulin resistance and some cardiovascular risk factors than body mass index.
    Elbassuoni E
    Endocr Regul; 2013 Jan; 47(1):3-14. PubMed ID: 23363252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
    Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
    J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Disease, Mortality Risk, and Healthcare Costs by Lipoprotein(a) Levels According to Low-density Lipoprotein Cholesterol Levels in Older High-risk Adults.
    Zhao Y; Delaney JA; Quek RG; Gardin JM; Hirsch CH; Gandra SR; Wong ND
    Clin Cardiol; 2016 Jul; 39(7):413-20. PubMed ID: 27177347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe.
    Orchard TJ; Stevens LK; Forrest KY; Fuller JH
    Int J Epidemiol; 1998 Dec; 27(6):976-83. PubMed ID: 10024191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.
    Ghandehari H; Le V; Kamal-Bahl S; Bassin SL; Wong ND
    Int J Obes (Lond); 2009 Feb; 33(2):239-48. PubMed ID: 19050677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of metabolic alterations predictive of cardiovascular disease risk in the Québec population.
    Scarsella C; Alméras N; Mauriège P; Blanchet C; Sauvé L; Dewailly E; Bergeron J; Després JP
    Can J Cardiol; 2003 Jan; 19(1):51-7. PubMed ID: 12571695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.